(Q27488759)

1

0 references

K A Im

3

0 references

J Wang

4

0 references

J Li

5

0 references

T Bugawan

6

0 references

L Jeffers

7

0 references

X Tong

8

0 references

X Su

9

0 references

H R Rosen

10

0 references

L J Yee

11

0 references

T J Liang

12

0 references

H Yang

A study of 82 extended HLA haplotypes in HFE-C282Y homozygous hemochromatosis subjects: relationship to the genetic control of CD8+ T-lymphocyte numbers and severity of iron overload

13

0 references

publication date

June 2008

0 references

published in

Genes and Immunity

0 references

volume

9

0 references

issue

4

0 references

page(s)

328-33

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696808

Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696808

Inference of population structure using multilocus genotype data

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696808

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696808

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696808

A comparative review of HLA associations with hepatitis B and C viral infections across global populations

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696808

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696808

A modified poisson regression approach to prospective studies with binary data

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696808

Population samples and genotyping technology.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696808

Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696808

The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696808

Association mapping in structured populations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696808

Hepatitis C virus infection in the United States

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696808

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

29 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.21

Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.21

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.21

Distribution of the HLA class I allele in chronic hepatitis C and its association with serum ALT level in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.21

Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.21

Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.21

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.21

Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.21

Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.21

Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2008.21